These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
158 related articles for article (PubMed ID: 7875184)
1. The psychomotor and cognitive effects of a new antihistamine, mizolastine, compared to terfenadine, triprolidine and placebo in healthy volunteers. Kerr JS; Dunmore C; Hindmarch I Eur J Clin Pharmacol; 1994; 47(4):331-5. PubMed ID: 7875184 [TBL] [Abstract][Full Text] [Related]
2. The effects of single and repeated administration of ebastine on cognition and psychomotor performance in comparison to triprolidine and placebo in healthy volunteers. Hindmarch ; Shamsi Z Curr Med Res Opin; 2001; 17(4):273-81. PubMed ID: 11922401 [TBL] [Abstract][Full Text] [Related]
3. An evaluation of the effects of high-dose fexofenadine on the central nervous system: a double-blind, placebo-controlled study in healthy volunteers. Hindmarch I; Shamsi Z; Kimber S Clin Exp Allergy; 2002 Jan; 32(1):133-9. PubMed ID: 12002730 [TBL] [Abstract][Full Text] [Related]
4. A single-center, randomized, double-blind, placebo-controlled, crossover investigation of the effects of fexofenadine hydrochloride 180 mg alone and with alcohol, with hydroxyzine hydrochloride 50 mg as a positive internal control, on aspects of cognitive and psychomotor function related to driving a car. Ridout F; Shamsi Z; Meadows R; Johnson S; Hindmarch I Clin Ther; 2003 May; 25(5):1518-38. PubMed ID: 12867226 [TBL] [Abstract][Full Text] [Related]
5. Lack of interaction between a new antihistamine, mizolastine, and lorazepam on psychomotor performance and memory in healthy volunteers. Patat A; Perault MC; Vandel B; Ulliac N; Zieleniuk I; Rosenzweig P Br J Clin Pharmacol; 1995 Jan; 39(1):31-8. PubMed ID: 7756096 [TBL] [Abstract][Full Text] [Related]
6. A double-blind, placebo-controlled investigation of the effects of fexofenadine, loratadine and promethazine on cognitive and psychomotor function. Hindmarch I; Shamsi Z; Stanley N; Fairweather DB Br J Clin Pharmacol; 1999 Aug; 48(2):200-6. PubMed ID: 10417497 [TBL] [Abstract][Full Text] [Related]
7. Effects of a sedative and of a non-sedative H1-antihistamine on the event-related potential (ERP) in normal volunteers. Swire FM; Marsden CA; Barber C; Birmingham AT Psychopharmacology (Berl); 1989; 98(3):425-9. PubMed ID: 2568660 [TBL] [Abstract][Full Text] [Related]
8. Lack of interaction between two antihistamines, mizolastine and cetirizine, and ethanol in psychomotor and driving performance in healthy subjects. Patat A; Stubbs D; Dunmore C; Ulliac N; Sexton B; Zieleniuk I; Irving A; Jones W Eur J Clin Pharmacol; 1995; 48(2):143-50. PubMed ID: 7589029 [TBL] [Abstract][Full Text] [Related]
9. Effects of mizolastine, a new antihistamine, on psychomotor performance and memory in elderly subjects. Patat A; Gram LF; Dubruc C; Brohier S; Cabanis MJ; Rosenzweig P Int Clin Psychopharmacol; 1994; 9(2):101-8. PubMed ID: 8056991 [TBL] [Abstract][Full Text] [Related]
10. Comparative wheal and flare study of mizolastine vs terfenadine, cetirizine, loratadine and placebo in healthy volunteers. Rosenzweig P; Caplain H; Chaufour S; Ulliac N; Cabanis MJ; Thebault JJ Br J Clin Pharmacol; 1995 Nov; 40(5):459-65. PubMed ID: 8703650 [TBL] [Abstract][Full Text] [Related]
11. Performance studies with the H1-histamine receptor antagonists, astemizole and terfenadine. Nicholson AN; Stone BM Br J Clin Pharmacol; 1982 Feb; 13(2):199-202. PubMed ID: 6120713 [TBL] [Abstract][Full Text] [Related]
12. Lack of behavioural toxicity of mizolastine: a review of the clinical pharmacology studies. Rosenzweig P; Patat A Clin Exp Allergy; 1999 Jul; 29 Suppl 3():156-62. PubMed ID: 10444231 [TBL] [Abstract][Full Text] [Related]
13. Effects of mizolastine and clemastine on actual driving and psychomotor performance in healthy volunteers. Vuurman EF; Uiterwijk MM; Rosenzweig P; O'Hanlon JF Eur J Clin Pharmacol; 1994; 47(3):253-9. PubMed ID: 7867678 [TBL] [Abstract][Full Text] [Related]
14. The effects of acrivastine (BW825C), diphenhydramine and terfenadine in combination with alcohol on human CNS performance. Cohen AF; Hamilton MJ; Peck AW Eur J Clin Pharmacol; 1987; 32(3):279-88. PubMed ID: 2885203 [TBL] [Abstract][Full Text] [Related]
15. The H1-antagonist mequitazine: studies on performance and visual function. Nicholson AN; Stone BM Eur J Clin Pharmacol; 1983; 25(4):563-6. PubMed ID: 6418550 [TBL] [Abstract][Full Text] [Related]
16. The effects of acute doses of fexofenadine, promethazine, and placebo on cognitive and psychomotor function in healthy Japanese volunteers. Ridout F; Hindmarch I Ann Allergy Asthma Immunol; 2003 Apr; 90(4):404-10. PubMed ID: 12722962 [TBL] [Abstract][Full Text] [Related]
17. The acute and sub-chronic effects of levocetirizine, cetirizine, loratadine, promethazine and placebo on cognitive function, psychomotor performance, and weal and flare. Hindmarch I; Johnson S; Meadows R; Kirkpatrick T; Shamsi Z Curr Med Res Opin; 2001; 17(4):241-55. PubMed ID: 11922397 [TBL] [Abstract][Full Text] [Related]
18. Variations among non-sedating antihistamines: are there real differences? Mattila MJ; Paakkari I Eur J Clin Pharmacol; 1999 Apr; 55(2):85-93. PubMed ID: 10335901 [TBL] [Abstract][Full Text] [Related]
19. Acute and subchronic effects of the H1-histamine receptor antagonist ebastine in 10, 20 and 30 mg dose, and triprolidine 10 mg on car driving performance. Brookhuis KA; De Vries G; De Waard D Br J Clin Pharmacol; 1993 Jul; 36(1):67-70. PubMed ID: 8104017 [TBL] [Abstract][Full Text] [Related]
20. Effects of two antihistamine drugs on actual driving performance. Betts T; Markman D; Debenham S; Mortiboy D; McKevitt T Br Med J (Clin Res Ed); 1984 Jan; 288(6413):281-2. PubMed ID: 6140978 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]